The zirconocene complex [Cp 2 ZrMe] + reacts with 2,4-dimethyl-1-pentene to give methane and the allyl complex [Cp 2 Zr(η 3 -CH 2 C(CH 2 CHMe 2 )CH 2 )] + . The reaction involves as an intermediate the unprecedented alkyl η 1 -alkene complex [Cp 2 Zr(Me)(η 1 -CH 2 CMeCH 2 CHMe 2 )] +, in which C(2) is essentially carbocationic and the C(1)−C(2) bond order is sufficiently low that rotation about it occurs. The hydrogen atoms of the methyl group on C(2) are sufficiently acidic that proton transfer to the Zr−Me group occurs to generate the allylic product. It seems likely that the chemistry described here provides a rationale for deactivation of propene polymerization catalysts since the normal products of chain transfer, polymers with vinylidene end groups, should form allylic species in the same way.
No takes yet. Share an insight, caveat, or question.
Vatamanu et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: